Comparison of Aspirin resistance in type 1 versus type 2 diabetes mellitus

American Journal of Cardiology

Volumn 97, Issue 4, 2006, Pages 567-570

  Mehta, Sheena S ^a   Silver, Robert J ^a   Aaronson, Arthur ^a   Abrahamson, Martin ^a   Goldfine, Allison B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DICLOFENAC; DIPYRIDAMOLE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; IBUPROFEN; INDOMETACIN; NAPROXEN; PIROXICAM; TICLOPIDINE;

ARTICLE; ASSAY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DOSE RESPONSE; DRUG TOLERANCE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; SEX FACTORS;

EID: 31944439729     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.09.093     Document Type: Article

References (20)

1. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy - I prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
2. M. Sacco, F. Pellegrini, M.C. Roncaglioni, F. Avanzini, G. Tognoni, A. Nicolucci PPP Collaborative Group Primary prevention of cardiovascular events with low-dose aspirin and Vitamin E in type 2 diabetic patients results of the Primary Prevention Project (PPP) trial Diabetes Care 26 2003 3264 3272
3. W.H. Chen, P.Y. Lee, W. Ng, J.Y.Y. Kwok, X. Cheng, H.F. Tse, C.P. Lau Prevalence, profile and predictors of aspirin resistance measured by the Ultegra Rapid Platelet Function Assay-ASA in patients with coronary artery disease J Am Coll Cardiol 45 2005 382A
4. J.A. Colwell, R.W. Nesto The platelet in diabetes focus on prevention of ischemic events Diabetes Care 26 2003 2181 2188
5. J. Sagel, J.A. Colwell, L. Crook, M. Laimins Increased platelet aggregation in early diabetes mellitus Ann Intern Med 82 1975 733 738
6. American Diabetes Association Aspirin therapy in diabetes Diabetes Care 23 2000 S61 S62
7. T.A. Pearson, S.N. Blair, S.R. Daniels, R.H. Eckel, J.M. Fair, S.P. Fortmann, B.A. Franklin, L.B. Goldstein, P. Greenland, S.M. Grundy AHA guidelines for primary prevention of cardiovascular disease and stroke 2002 update Circulation 106 2002 388 391
8. V. Evangelista, L. Totani, S. Rotondo, R. Lorenzet, G. Tognoni, G. De Berardis, I. Nicolucci Prevention of cardiovascular disease in type-2 diabetes how to improve the clinical efficacy of aspirin Thromb Haemost 93 2005 8 16
9. P.A. Gum, K. Kottke-Marchant, E.D. Poggio, H. Gurm, P.A. Welsh, L. Brooks, S.K. Sapp, E.J. Topol Profile and prevalence of aspirin resistance in patients with cardiovascular disease Am J Cardiol 88 2001 230 235
10. P.A. Gum, K. Kottke-Marchant, P.A. Welsh, J. White, E.J. Topol A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol 41 2003 961 965
11. C.M. Helgason, K.L. Tortorice, S.R. Winkler, D.W. Penney, J.J. Schuler, T.J. McClelland, L.D. Brace Aspirin response and failure in cerebral infarction Stroke 24 1993 345 350
12. C.M. Helgason, K.M. Bolin, J.A. Hoff, S.R. Winkler, A. Mangat, K.L. Tortorice, L.D. Brace Development of aspirin resistance in persons with previous ischemic stroke Stroke 25 1994 2331 2336
13. Kiss RG, Stef GY, Kerecsen G, Poor F, Seres E, Pongraz E, Nemeth L, Preda I. Continuation of aspirin therapy despite aspirin resistance is associated with higher mortality. A two-year follow-up, five center experience in 921 cardiovascular patients (abstr). Available at: http://cic.escardio.org/ AbstractDetails.aspx?id=13578. Accessed 2005.
14. A.D. Michelson, M. Cattaneo, J.W. Eikelboom, S.P. Gurbel, K. Kottke-Marchant, T.J. Kunicki, F.M. Pulcinelli, C. Cerlettiss, A.K. Rao Aspirin resistance position paper of the Working Group on Aspirin Resistance J Thromb Haemost 3 2005 1309 1311
15. J.W. Eikelboom, J. Hirsh, J.I. Weitz, M. Johnston, Q. Yi, S. Yusuf Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events Circulation 105 2002 1650 1655
16. K. Andersen, M. Hurlen, H. Arnesen, I. Seljeflot Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease Thromb Res 108 2002 37 42
17. P.Y. Lee, W.H. Chen, W. Ng, X. Cheng, J.Y. Kwok, H.F. Tse, C.P. Lau Low-dose aspirin increases aspirin resistance in patients with coronary artery disease Am J Med 118 2005 723 727
18. P.M. Ridker, N.R. Cook, I.M. Lee, D. Gordon, J.M. Gaziano, J.E. Manson, C.H. Hennekens, J.E. Buring A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N Engl J Med 31 2005 1293 1304
19. J.C. Wang, D. Aucoin-Barry, D. Manuelian, R. Monbouquette, M. Reisman, W. Gray, P.C. Block, E.H. Block, M. Ladenheim, D.I. Simon Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA Am J Cardiol 92 2003 1492 1494
20. S. Fateh-Moghadam, U. Plockinger, N. Cabeza, P. Htun, T. Reuter, S. Ersel, M. Gawaz, R. Dietz, W. Bocksch Prevalence of aspirin resistance in patients with type 2 diabetes Acta Diabetol 42 2005 99 103